Fumitake Saito
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Humoral immunity after LP.8.1 monovalent vaccines against a broad range of SARS-CoV-2 variants including XEC, LP.8.1, NB.1.8.1, XFG, and BA.3.2.
Journal: The Lancet. Infectious diseases
Published: November 18, 2025
Induced lung epithelial-like cells derived by direct reprogramming rescue influenza virus-induced lung injury in mice.
Journal: Biochemical and biophysical research communications
Published: July 14, 2025
Antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against SARS-CoV-2 omicron subvariants including JN.1, KP.3.1.1, and XEC.
Journal: The Lancet. Infectious diseases
Published: November 20, 2024
Chronic obstructive pulmonary disease, asthma, and mechanical ventilation are risk factors for dyspnea in patients with long COVID: A Japanese nationwide cohort study.
Journal: Respiratory investigation
Published: July 24, 2024
Social impact of brain fog and analysis of risk factors: Long COVID in Japanese population.
Journal: Annals of clinical and translational neurology
Published: February 22, 2024
Direct reprogramming of mouse fibroblasts into self-renewable alveolar epithelial-like cells.
Journal: NPJ Regenerative medicine
Published: February 11, 2024
Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals.
Journal: The Lancet. Infectious diseases
Published: November 29, 2023
Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study.
Journal: Respiratory investigation
Published: March 13, 2023
Clinical characteristics of the first three waves of hospitalised patients with COVID-19 in Japan prior to the widespread use of vaccination: a nationwide observational study.
Journal: The Lancet regional health. Western Pacific
Published: March 18, 2022
Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan.
Journal: Infectious diseases and therapy
Published: January 24, 2022
Effectiveness of remdesivir in hospitalized nonsevere patients with COVID-19 in Japan: A large observational study using the COVID-19 Registry Japan.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 17, 2022
Last Updated: 09/26/2026